子宫肉瘤与子宫肌瘤的MUSA术语及定义超声特征:队列研究
这项回顾性队列研究纳入107例患者(子宫肉瘤16例、子宫肌瘤91例),由两名超声医师依据MUSA术语与定义独立复评超声图像。子宫肉瘤更多见于年龄较大、绝经后患者,且肿瘤边界多不规则、病灶内血流中等至丰富;多数MUSA术语的观察者间一致性为中等。
要点
- 子宫肉瘤患者中位年龄65岁、81%绝经后,明显高于子宫肌瘤患者的48岁与16%。
- 多数子宫肉瘤肿瘤边界不规则(两名观察者分别为11/16与13/16),而多数子宫肌瘤边界规则。
- 多数MUSA术语观察者间一致性为中等,病灶形状、边界与回声一致性为一般。
核心结论
- 绝经后异常子宫出血、新发或增大的间叶性肿块且超声示边界不规则、病灶内血流中等至丰富、囊性区及无钙化者,子宫肉瘤风险较高。
- 多数MUSA术语与定义的观察者间一致性为中等。
- 作者认为未来应以前瞻性多中心方式验证上述子宫间叶肿瘤的临床与超声表现。
研究设计与样本
- 回顾性队列研究,纳入单一三级中心1997—2019年治疗的子宫肉瘤患者及2016—2019年治疗的子宫肌瘤患者。
- 共纳入107例,其中子宫肉瘤16例、子宫肌瘤91例;由两名超声医师依据MUSA术语与定义独立复评超声图像。
- 采用描述性统计,观察者间一致性按情况用Cohen's κ(平方加权)或组内相关系数评估。
主要发现
- 异常子宫出血为最常见就诊症状(69/107,64%)。
- 子宫肉瘤患者中位年龄65岁(四分位距60-70岁)vs 子宫肌瘤48岁(四分位距43-52岁);绝经后比例13/16(81%)vs 15/91(16%)。
- 子宫肉瘤中最常见组织学类型为平滑肌肉瘤(6/16,38%),其次为腺肉瘤(4/16,25%)。
- 观察者1与观察者2分别报告肿瘤边界不规则于11/16(69%)与13/16(81%)的子宫肉瘤,而边界规则见于65/91(71%)与82/91(90%)的子宫肌瘤。
- 观察者1与观察者2分别将68/91(75%)与51/91(56%)的子宫肌瘤判为回声不均匀,两名观察者均将15/16(94%)的子宫肉瘤判为回声不均匀。
关键数值与推荐
- 子宫肉瘤中声影见于观察者1的11/16(69%)与观察者2的10/16(63%),钙化仅见于0/16(0%)与2/16(13%)。
- 子宫肉瘤病灶内血流中等至丰富见于观察者1的13/16(81%)与观察者2的15/16(94%);周边血流中等至丰富两名观察者均为6/16(38%)。
- 囊性区、钙化、声影、中央坏死、彩色评分(总体、病灶内、周边)及病灶最大径的观察者间一致性为中等;病灶形状、肿瘤边界与回声的一致性为一般。
局限性
- 原文为回顾性队列研究。
- 研究在单一三级中心进行。
- 作者认为未来需以前瞻性多中心研究验证上述临床与超声表现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Timely and accurate preoperative diagnosis of uterine sarcoma will increase patient survival. The primary aim of this study was to describe the ultrasound features of uterine sarcoma compared with those of uterine leiomyoma based on the terms and definitions of the Morphological Uterus Sonographic Assessment (MUSA) group. A secondary aim was to assess the interobserver agreement for reporting on ultrasound features according to MUSA terminology. METHODS: This was a retrospective cohort study of patients with uterine sarcoma or uterine leiomyoma treated in a single tertiary center during the periods 1997-2019 and 2016-2019, respectively. Demographic characteristics, presenting symptoms and surgical outcomes were extracted from patients' files. Ultrasound images were re-evaluated independently by two sonologists using MUSA terms and definitions. Descriptive statistics were calculated and interobserver agreement was assessed using Cohen's κ (with squared weights) or intraclass correlation coefficient, as appropriate. RESULTS: A total of 107 patients were included, of whom 16 had a uterine sarcoma and 91 had a uterine leiomyoma. Abnormal uterine bleeding was the most frequent presenting symptom (69/107 (64%)). Compared with leiomyoma cases, patients with uterine sarcoma were older (median age, 65 (interquartile range (IQR), 60-70) years vs 48 (IQR, 43-52) years) and more likely to be postmenopausal (13/16 (81%) vs 15/91 (16%)). In the uterine sarcoma cohort, leiomyosarcoma was the most frequent histological type (6/16 (38%)), followed by adenosarcoma (4/16 (25%)). On ultrasound evaluation, according to Observers 1 and 2, the tumor border was irregular in most sarcomas (11/16 (69%) and 13/16 (81%) cases, respectively), but regular in most leiomyomas (65/91 (71%) and 82/91 (90%) cases, respectively). Lesion echogenicity was classified as non-uniform in 68/91 (75%) and 51/91 (56%) leiomyomas by Observers 1 and 2, respectively, and 15/16 (94%) uterine sarcomas by both observers. More than 60% of the uterine sarcomas showed acoustic shadows (11/16 (69%) and 10/16 (63%) cases by Observers 1 and 2, respectively), whereas calcifications were reported in a small minority (0/16 (0%) and 2/16 (13%) cases by Observers 1 and 2, respectively). In uterine sarcomas, intralesional vascularity was reported as moderate to abundant in 13/16 (81%) cases by Observer 1 and 15/16 (94%) cases by Observer 2, while circumferential vascularity was scored as moderate to abundant in 6/16 (38%) by both observers. Interobserver agreement for the presence of cystic areas, calcifications, acoustic shadow, central necrosis, color score (overall, intralesional and circumferential) and maximum diameter of the lesion was moderate. The agreement for shape of lesion, tumor border and echogenicity was fair. CONCLUSIONS: A postmenopausal patient presenting with abnormal uterine bleeding and a new or growing mesenchymal mass with irregular tumor borders, moderate-to-abundant intralesional vascularity, cystic areas and an absence of calcifications on ultrasonography is at a higher risk of having a uterine sarcoma. Interobserver agreement for most MUSA terms and definitions is moderate. Future studies should validate the abovementioned clinical and ultrasound findings on uterine mesenchymal tumors in a prospective multicenter fashion. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- De Bruyn C, Ceusters J, Vanden Brande K, et al. Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study. Ultrasound Obstet Gynecol. 2024. PMID: 37970762. doi:10.1002/uog.27535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。